（ビジネスワイヤ） -- 新規抗体治療法の発見と開発に取り組む世界的バイオテクノロジー企業のバイオサイトジェン（HKEX：02315）は、PPFグループ傘下の臨床段階向けバイオ医薬品企業であるソティオ・バイオテックとの完全ヒト抗体のライセンス契約を発表しました。このライセンス契約は、両社間で成立した ...
Areteia Therapeutics, Inc. («Areteia»), empresa biotecnológica de fase clínica que desarrolla novedosas terapias contra la ...
BlueSnap, a global payment orchestration platform for leading B2B and B2C businesses, today announced its selection by MarginEdge, a provider of resta ...
DDN, a global leader in AI and data intelligence solutions, today announced it has received a $300 million investment from ...
F45 Training Holdings Inc., a leading global fitness community known for innovative, high-energy group workouts, announced ...
The median U.S. asking rent fell 0.3% year over year in December to $1,594—the lowest level since March 2022. That’s ...
World of Hyatt members can earn and redeem points at The Venetian Resort Las Vegas on qualifying stays when booked through ...
Valspring Capital, a healthcare-focused growth equity firm, today announced the close of the firm’s debut fund, Valspring ...
NSF, a global services organization, is excited to announce its reauthorization as a CMMC Third-Party Assessment Organization ...
Maxar Intelligence, a provider of secure, precise geospatial insights, today announced it was awarded a €13.6M ($14.4M) framework contract by the Neth ...
SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for patients with coronary artery disease (CAD), today an ...
GeneDx launches new telehealth testing pathway to connect parents directly with genetic experts to increase access to exome and genome testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback